Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other Non-Current Liabilities: 2020

  • Tango Therapeutics' Other Non-Current Liabilities was N/A to $5,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $5,000, marking a year-over-year change of. This contributed to the annual value of $5,000 for FY2020, which is N/A change from last year.
  • According to the latest figures from Q4 2020, Tango Therapeutics' Other Non-Current Liabilities is $5,000.
  • In the past 5 years, Tango Therapeutics' Other Non-Current Liabilities ranged from a high of $5,000 in Q4 2020 and a low of $5,000 during Q4 2020.
  • Over the past 1 years, Tango Therapeutics' median Other Non-Current Liabilities value was $5,000 (recorded in 2020), while the average stood at $5,000.